Company / Debt per Share
Inhibrx Biosciences, Inc. Debt per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Debt per Share
$6.95
FY2025
5-year range
$0.00 / $17.56
FY2023-FY2025
Trend
-
vs FY2024
Sector context
#32 of 82
Health Care
What the data says
At $6.95, Inhibrx Biosciences, Inc.'s debt per share ranks #51 of 82 in the Health Care sector. Improved from $17.56 to $6.95 over the past 2 years.
Based on SEC 10-K filings.
6.95 in FY2025.
Improved from $17.56 to $6.95 over the past 2 years.
Health Care sector context is included.
Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#51 of 82 in Health CareTop 61% of 82This company $6.95 Sector average $151.59
▼
-95.4% below sector average
Key checks
Key Insights
- Ranks #32 out of 82 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -3.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.95 | - |
| FY2024 | $0.00 | -100.0% |
| FY2023 | $17.56 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026